Ashton Thomas Securities’s CONMED CNMD Stock Holding History

Ashton Thomas Securities’s Portfolio CNMD Stock Details CNMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-25	Closed	-$1.8K	–	419
2024 Q3	$1.8K	Buy	+25	New	+$1.76K	﹤0.01%	1127

Other funds holding CNMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Ashton Thomas Securities's CNMD Position: Q4 2024 in Review

Ashton Thomas Securities sold out of CONMED (CNMD) in Q4 2024, closing a stake of 25 shares — an estimated $1.8K sold.

Ashton Thomas Securities first reported a position in CNMD in Q3 2024 and held it in 1 quarter. The position peaked at $1.8K in Q3 2024. 280 funds tracked by Wall St. Rank hold CNMD as of Q4 2024.

Ashton Thomas Securities reported no remaining CONMED position as of Q4 2024 after selling out during the quarter.
Ashton Thomas Securities sold 25 CONMED shares in Q4 2024, an estimated $1.8K.
Ashton Thomas Securities first reported a position in CONMED in Q3 2024 and held it in 1 quarter.
Ashton Thomas Securities's CONMED position peaked at $1.8K in Q3 2024.
280 funds tracked by Wall St. Rank held CONMED as of Q4 2024.

Based on Ashton Thomas Securities's 13F filing for Q4 2024, filed 11 Feb 2025.